Category: Manufacturing

April 13, 2022

VectorBuilder, a global gene delivery solutions company, announced on April 11, 2022 the construction of a new $500 million R&D and manufacturing center in Guangzhou, China. The ‘Gene Delivery Research and Manufacturing Campus’ will aid in the growth of the […]

April 7, 2022

Catalent announced on April 6, 2022 that it has acquired Vaccine Manufacturing and Innovation Centre UK Limited’s biologics development and manufacturing facility currently under construction near Oxford, United Kingdom. Catalent plans to invest up to US$160 million (£120 million) into […]

April 1, 2022

Despite the pandemic, FDA has worked to maintain appropriate oversight of biopharmaceutical production activities, while also advancing strategies to encourage industry adoption of advanced manufacturing systems. The larger goals of enhanced quality production are to prevent drug shortages and ensure […]

March 31, 2022

German pharma giant Bayer plans to spend 2 billion euros ($2.2 billion) over the next three years to upgrade its manufacturing and supply chain capabilities as it dives deeper into cell and gene therapies. As part of the effort, the […]

March 16, 2022

CMC Pharmaceuticals, a provider of drug product development services to the pharmaceutical and biotech industries, has entered a partnership with Federal Equipment Company, a dealer of industrial processing equipment with a focus on pharmaceutical and chemical manufacturing. This agreement grants […]

March 10, 2022

Actym Therapeutics, a biotech focused on the discovery and development of novel cancer therapies, and Wacker Biotech, have signed a contract for the manufacturing of Actym’s lead clinical candidate, ACTM-838, for the treatment of solid tumors. Wacker Biotech will initiate […]

March 4, 2022

FDA’s Center for Drug Evaluation and Research (CDER) continues to make rare diseases a priority with teams and programs dedicated to speeding up therapeutic development. Both government incentives and scientific advancements have allowed for drug development for rare diseases. According […]

March 3, 2022

Atlas is closing this fund amid one of the most severe biotech downturns in years, a retrenchment that’s constrained the options of private drug companies seeking to make the jump to public markets. Few biotechs are now pricing initial public […]

March 1, 2022

In April 2020, a clarion call by Outsourced Pharma set a major goal in “A Declaration of Drug Independence.” This call sought to “… dedicate ourselves to the goal of reducing US dependency on foreign sources for drug materials, intermediates, […]

February 21, 2022

BioNTech SE aims to improve vaccine supply in Africa by developing and delivering turnkey messenger RNA (mRNA) manufacturing facilities based on a container solution, the company said in a Feb. 16, 2022 press release. This modular-facility approach is designed to […]

February 17, 2022

Thermo Fisher Scientific announced that it is investing $40 million to expand its single-use technology manufacturing facility in Millersburg, Penn. The expansion is part of a $650 million multi-year investment to enhance the company’s ability to provide flexible, scalable, and […]

February 3, 2022

B. Braun Medical, a German infusion therapy company, has received the FDA’s approval to begin operations at its new IV saline solution manufacturing facility in Daytona Beach, Florida. The facility, which is part of the company’s pledge to spend $1 […]

January 28, 2022

Homology Medicines has found a source of fresh funding. With its share price in the doldrums and its cash runway nearing its final year, Homology is offloading manufacturing assets through a joint venture to raise $130 million for clinical development […]

January 18, 2022

Stanford University spinout N1 Life has formed a joint venture to further its drug delivery ambitions. The startup is teaming up with Accuredit Therapeutics to create a joint venture, Napoltec, focused on novel drug delivery systems and the progression of […]

January 18, 2022

Ori Biotech, which is on the cusp of launching an innovative process for manufacturing cell and gene therapies (CGTs), tallied more than $100 million in its latest funding round. The company will use the money to add key personnel in […]

January 18, 2022

Samsung Biologics announced on Jan. 12, 2022 that it plans to start building a new facility (designated Plant 5) at Songdo in Incheon, South Korea, this year. The facility will offer manufacturing for multi-modal products, including cell and gene therapies […]

December 28, 2021

Anton Middelberg, PhD, deputy vice-chancellor and vice-president of research at the University of Adelaide in Australia, believes industry reluctance to go continuous reflects the traditional focus on batch-mode production and, in some areas, the technical challenges. “The complexity in continuous […]

December 21, 2021

Continuous processing, for decades an essential characteristic of advanced large-scale manufacturing, has been adopted slowly for mammalian cell-based processes, and even more haltingly for microbial fermentations. In a recent paper in Frontiers in Bioengineering and Biotechnology, lead author Christoph Herwig, […]

December 14, 2021

Scientists have discovered a new potential treatment that could reverse antibiotic resistance in different Gram-negative bacteria that cause conditions including urinary tract infections, sepsis, or pneumonia. The collaborative research, headed by a team at the Ineos Oxford Institute (IOI) for […]

November 18, 2021

Bayer inked a deal with Syntegon Technology for access to a novel continuous manufacturing process for oral solid dosage forms. The process uses fluid bed granulation, which yields granules with improved properties, Syntegon said. The company acquired Bosch Packaging Technology […]